Literature DB >> 16682220

Interrupting poliovirus transmission -- new solutions to an old problem.

R Bruce Aylward1, Chris Maher.   

Abstract

Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, knowledge as to the nature of circulating polioviruses and the challenges to their interruption has increased tremendously, particularly during the period 2000-2005. By January 2006, however, the systematic application of the standard polio eradication strategies, combined with recent refinements, had reduced the number of countries with ongoing transmission of indigenous wild polioviruses to just four (Nigeria, India, Pakistan, and Afghanistan), the lowest ever in history. In addition, only 8 of the 22 areas that had been re-infected by wild poliovirus in 2003-2005 still required large-scale 'mop-up' activities and circulating vaccine-derived poliovirus (cVDPV) outbreaks were being readily addressed. This progress, despite new challenges late in the GPEI, was greatly facilitated by a range of solutions that included two new monovalent oral polio vaccines (mOPVs), new and robust international standards for polio outbreak response, and renewed political commitment across the remaining infected countries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682220     DOI: 10.1016/j.biologicals.2006.02.012

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  9 in total

1.  The human qualities needed to complete the global eradication of polio.

Authors:  Dermot Maher
Journal:  Bull World Health Organ       Date:  2013-01-24       Impact factor: 9.408

Review 2.  Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.

Authors:  Steven G F Wassilak; M Steven Oberste; Rudolph H Tangermann; Ousmane M Diop; Hamid S Jafari; Gregory L Armstrong
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

Review 3.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

4.  Determinants of health disparities: the perennial struggle against polio in Nigeria.

Authors:  Nosayaba Osazuwa-Peters
Journal:  Int J Prev Med       Date:  2011-07

5.  Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.

Authors:  Manish Patel; Stephen Cochi
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

6.  An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia.

Authors:  Rochelle E Watkins; P Anthony J Martin; Heath Kelly; Ben Madin; Charles Watson
Journal:  BMC Infect Dis       Date:  2009-09-30       Impact factor: 3.090

7.  Assessing the effectiveness of house-to-house visits on routine oral polio immunization completion and tracking of defaulters.

Authors:  Dora Ward Curry; Henry B Perry; Syed N Tirmizi; Allison L Goldstein; Meg C Lynch
Journal:  J Health Popul Nutr       Date:  2014-06       Impact factor: 2.000

Review 8.  Eradication and Current Status of Poliomyelitis in Pakistan: Ground Realities.

Authors:  Shazia Ghafoor; Nadeem Sheikh
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

9.  Applying the Concept of Peptide Uniqueness to Anti-Polio Vaccination.

Authors:  Darja Kanduc; Candida Fasano; Giovanni Capone; Antonella Pesce Delfino; Michele Calabrò; Lorenzo Polimeno
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.